These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1957799)

  • 1. AIDS, death, and the drug approval process.
    Berger JW
    Am Pharm; 1991 Oct; NS31(10):45, 47. PubMed ID: 1957799
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug approval and AIDS: benefits for the elderly.
    Rothman DJ; Edgar H
    Health Aff (Millwood); 1990; 9(3):123-30. PubMed ID: 2227773
    [No Abstract]   [Full Text] [Related]  

  • 3. AIDS, safety, and the drug approval process.
    Uzych L
    Am Pharm; 1991 Oct; NS31(10):44, 46. PubMed ID: 1957798
    [No Abstract]   [Full Text] [Related]  

  • 4. 124 drugs currently in development.
    AIDS Patient Care STDS; 1998 Feb; 12(2):149. PubMed ID: 11361916
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA approves AIDS drug.
    Am Pharm; 1992 Sep; NS32(9):13-4. PubMed ID: 1332462
    [No Abstract]   [Full Text] [Related]  

  • 6. Executive summary from the final reports of the National Committee to Review Current Procedures for Approval of New Drugs for Cancer and AIDS.
    Oncology (Williston Park); 1991 Apr; 5(4):16, 18-9. PubMed ID: 1831034
    [No Abstract]   [Full Text] [Related]  

  • 7. The fast track toward new AIDS drugs.
    Long K; Long R
    Nurse Pract Forum; 1991 Jun; 2(2):80-1. PubMed ID: 1840952
    [No Abstract]   [Full Text] [Related]  

  • 8. DdI approval offers second chance.
    Albert SG
    Am Pharm; 1991 Dec; NS31(12):6. PubMed ID: 1763779
    [No Abstract]   [Full Text] [Related]  

  • 9. The AIDS epidemic and clinical trials.
    Young FE
    Acad Med; 1989 Nov; 64(11):660-1. PubMed ID: 2803424
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA 'pushing envelope' on AIDS drug.
    Cotton P
    JAMA; 1991 Aug; 266(6):757-8. PubMed ID: 1907668
    [No Abstract]   [Full Text] [Related]  

  • 11. AIDS drugs in development. Facts and comparisons.
    Hosp Pharm; 1993 Feb; 28(2):161, 165-7. PubMed ID: 10125704
    [No Abstract]   [Full Text] [Related]  

  • 12. Overhaul at the FDA begins.
    Science; 1992 Apr; 256(5055):313. PubMed ID: 1566081
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulatory hierarchies.
    Oldham RK
    Mol Biother; 1988; 1(1):3-6. PubMed ID: 3267370
    [No Abstract]   [Full Text] [Related]  

  • 14. Methodological issues in AIDS clinical trials. Statutory and regulatory framework for drug approval.
    Burlington DB
    J Acquir Immune Defic Syndr (1988); 1990; 3 Suppl 2():S4-9. PubMed ID: 2231300
    [No Abstract]   [Full Text] [Related]  

  • 15. Treating seriously ill patients with experimental drugs.
    Palumbo FB
    Pharm Res; 1990 Oct; 7(10):988-9. PubMed ID: 2281044
    [No Abstract]   [Full Text] [Related]  

  • 16. HIV surrogate markers weighed.
    Cotton P
    JAMA; 1991 Mar; 265(11):1357, 1361-2. PubMed ID: 1671883
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk versus risk: decision-making dilemmas of drug regulation in the United States and Germany.
    Daemmrich A; Krucken G
    Sci Cult (Lond); 2000 Dec; 9(4):505-34. PubMed ID: 15988846
    [No Abstract]   [Full Text] [Related]  

  • 18. A shot in the arm for an AIDS vaccine.
    Newsweek; 1998 Jun; 131(24):62. PubMed ID: 10180631
    [No Abstract]   [Full Text] [Related]  

  • 19. The fast track: federal agencies and the political demand for AIDS drugs.
    Foreman CH
    Brookings Rev; 1991; 9(2):30-7. PubMed ID: 10110828
    [No Abstract]   [Full Text] [Related]  

  • 20. Experimental AIDS drug d4T, now available to patients in critical need.
    Ann Allergy; 1993 Sep; 71(3):A24. PubMed ID: 8396862
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.